University Hospital of Umeå, in Swedish Norrlands universitetssjukhus, is the major hospital in northern Sweden, situated in Umeå. The hospital employs 5,600 people.

During the past decade, Umeå University Hospital conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 7 clinical trials were completed, i.e. on average, 8.8% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 4 clinical trials were completed. i.e. 11.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Umeå University Hospital" #1 sponsor was "Umeå University" with 35 trials, followed by "Karolinska Institutet" with 8 trials sponsored, "Uppsala University" with 8 trials sponsored, "Pfizer" with 5 trials sponsored and "Lund University Hospital" with 5 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Umeå University Hospital" #1 collaborator was "Sahlgrenska University Hospital, Sweden" with 12 trials as a collaborator, "University Hospital, Umeå" with 12 trials as a collaborator, "University Hospital, Linkoeping" with 10 trials as a collaborator, "Skane University Hospital" with 9 trials as a collaborator and "Karolinska University Hospital" with 8 trials as a collaborator. Other collaborators include 219 different institutions and companies that were collaborators in the rest 150 trials.

According to Clinical.Site data, the most researched conditions in "Umeå University Hospital" are "Prostate Cancer" (5 trials), "Amyotrophic Lateral Sclerosis" (4 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials) and "Multiple Myeloma" (4 trials). Many other conditions were trialed in "Umeå University Hospital" in a lesser frequency.

Most popular intervention types in "Umeå University Hospital" are "Drug" (55 trials), "Other" (22 trials), "Procedure" (21 trials), "Device" (8 trials) and "Behavioral" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ibrutinib" (3 trials), "AMX0035" (2 trials), "Acetylsalicylic acid" (2 trials) and "Arimoclomol" (2 trials). Other intervention names were less common.

The vast majority of trials in "Umeå University Hospital" are 107 trials for "All" genders, 10 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are 56 active trials in "Umeå University Hospital". 1 are not yet recruiting, 39 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in Umeå University Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Umeå University Hospital, 2 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 42 trials that are defined as “Not Applicable".